How Antiretroviral Treatments Work for Patients with HIVAntiretroviral treatments play a vital role in managing HIV by suppressing viral replication and slowing down the progression of the disease.
Can Someone on Prep Pass on HIV?PrEP, stands for Pre-Exposure Prophylaxis, and is employed as a preventive strategy to decrease HIV transmission risk.
A new approach to design HIV vaccines based on germline antibodies and Env structuresA new study published in Nature Communications1 reports a new approach to design HIV vaccines based on the structures of germline antibodies and HIV envelope (Env) proteins.
A New Discovery About HIV Persistence: How Monocyte-Derived Macrophages Harbor Hidden Viral ReservoirsHuman immunodeficiency virus (HIV) is a virus that infects and destroys immune cells, leading to acquired immunodeficiency syndrome (AIDS), a condition that causes opportunistic infections and cancers.
A new HIV vaccine candidate shows promise in female macaquesA new study published in Nature Communications1 reports the efficacy and mechanism of action of a novel HIV vaccine candidate in female macaques.
A New Insight into HIV Evolution: How Natural Selection Favors More Infectious VirusesHuman immunodeficiency virus (HIV) is a virus that infects and destroys immune cells, leading to acquired immunodeficiency syndrome (AIDS), a condition that causes opportunistic infections and cancers.
A New Understanding of HIV Emergence: How Two Host Factors Shaped the Global EpidemicHuman immunodeficiency virus (HIV) is a virus that infects and destroys immune cells, leading to acquired immunodeficiency syndrome (AIDS), a condition that causes opportunistic infections and cancers.
A New Weapon Against HIV: How a Three-in-One Antibody Can Eradicate Hidden Viral ReservoirsHuman immunodeficiency virus (HIV) is a virus that infects and destroys immune cells, leading to acquired immunodeficiency syndrome (AIDS), a condition that causes opportunistic infections and cancers.
How effective is a third dose of COVID-19 mRNA vaccine for people living with HIV?A recent study published in Nature Communications1 investigated the safety and immunogenicity of a third dose of COVID-19 mRNA vaccine (either Pfizer-BioNTech or Moderna) in people living with HIV (PLWH) who have advanced disease (low CD4 count and/or previous AIDS diagnosis).
